Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Xiao‐Qing Guan, Yang Yang, Lanying Du
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 422-439
Open Access | Times Cited: 19
A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
JCI Insight (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 4
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
Xiaoqing Guan, Abhishek Kumar Verma, Qian Liu, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 293-293
Open Access
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
Juan Shi, Gang Wang, Jian Zheng, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 17
Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
Juan Shi, Zhao Yu, Min Peng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 713-713
Open Access | Times Cited: 10
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge
Gang Wang, Abhishek Kumar Verma, Xiao‐Qing Guan, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Closed Access | Times Cited: 3
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Gang Wang, Abhishek Kumar Verma, Juan Shi, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern
Gang Wang, Juan Shi, Abhishek Kumar Verma, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105690-105690
Open Access | Times Cited: 10
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
Xiao‐Qing Guan, Abhishek Kumar Verma, Gang Wang, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 108033-108033
Open Access | Times Cited: 5
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
Xiao‐Qing Guan, Abhishek Kumar Verma, Gang Wang, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 605-605
Open Access | Times Cited: 1
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access | Times Cited: 1
Novel B-Cell Epitopes of Non-Neutralizing Antibodies in the Receptor-Binding Domain of the SARS-CoV-2 S-Protein with Different Effects on the Severity of COVID-19
Andrey L. Matveev, Oleg V. Pyankov, Yana A. Khlusevich, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 9, pp. 1205-1214
Closed Access | Times Cited: 3
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
Daniele Focosi, Fabrizio Maggi
Viruses (2022) Vol. 14, Iss. 11, pp. 2488-2488
Open Access | Times Cited: 5
Fingerprinting trimeric SARS-CoV-2 RBD by capillary isoelectric focusing with whole-column imaging detection
Jialiang Du, Gang Wu, Quanyao Chen, et al.
Analytical Biochemistry (2022) Vol. 663, pp. 115034-115034
Open Access | Times Cited: 4
Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD
Qingyun Zhang, Yi Yang, Jun Lan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs
Valentina Ruocco, Ulrike Vavra, Julia König-Beihammer, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 1
The tobacco GNTI stem region harbors a strong motif for homomeric protein complex formation
Jennifer Schoberer, Shiva Izadi, Carolina Kierein, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 1
Exploring Immune Response and Lab Markers Across COVID-19 Severity Levels
Yulia Desheva, Tamara Shvedova, Anna Lerner, et al.
(2023)
Open Access | Times Cited: 1
Efficient Expression in Leishmania tarentolae (LEXSY) of the Receptor-Binding Domain of the SARS-CoV-2 S-Protein and the Acetylcholine-Binding Protein from Lymnaea stagnalis
Lina V. Son, V. Yu. Kost, V. N. Maǐorov, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 943-943
Open Access
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Cell‐Based Biomaterials for Coronavirus Disease 2019 Prevention and Therapy
Chuyu Li, Chenguang Wang, Hai‐Yan Xie, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 18
Open Access
Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
Navilla Apú, German Madrigal Redondo, María Herrera Vega, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access
Novel b-cell epitopes of non-neutralizing antibodies in the receptor-binding domain of the S-protein of SARS-CoV-2 with differing effects on the severity of the course of COVID-19
A. L. Matveev, Oleg V. Pyankov, Yana A. Khlusevich, et al.
Биохимия (2023) Vol. 88, Iss. 9, pp. 1461-1472
Closed Access
Immune response and laboratory markers in the spectrum of severity of COVID-19
Yulia Desheva, Tamara Shvedova, Polina Kudar, et al.
Medical academic journal (2023) Vol. 23, Iss. 4, pp. 85-94
Closed Access
Page 1

Scroll to top